Skip to main content
. 2021 Sep 14;16(9):e0257424. doi: 10.1371/journal.pone.0257424

Table 5. Comparison of the top ten oral antibacterials consumed between sectors.

Public sector Private Sector
ABM AWaRe group DDDs in million % ABM AWaRe group DDDs in million %
Amoxicillin A 21.91 28.96 Co-Amoxiclav A 38.95 15.89
Cloxacillin A 7.82 10.33 Azithromycin W 38.74 15.81
Cefuroxime W 6.7 8.86 Ciprofloxacin W 34.91 14.25
Co-Amoxiclav A 6.2 8.2 Amoxicillin A 22.66 9.25
Doxycycline A 5.94 7.85 Cefuroxime W 20.7 8.45
Ciprofloxacin W 5.81 7.68 Cephalexin A 16.12 6.58
Metronidazole A 4.62 6.11 Doxycycline A 14.35 5.86
Cephalexin A 4.57 6.04 Clarithromycin W 13.49 5.5
Erythromycin W 3.52 4.66 Metronidazole A 12.03 4.91
Clarithromycin W 2.62 3.47 Levofloxacin W 8.03 3.28